Ruti Alon

Ms. Alon currently serves as a Board Member for Vascular Biogenics (VBLT), Phoska Biopharma Pte Ltd., BlueTree Ltd and Moringa Acquisition Corp (MACAU), in addition to serving as a Chairperson for BrainsGate. Previously, Ms. Alon was a General Partner at Pitango Venture Capital, the largest venture capital fund in Israel, where she established and led investments in the life sciences sector and served as a Board member and Chair for multiple companies ultimately acquired by top innovators in the industry. Earlier in her career, Ms. Alon was a Senior Healthcare Analyst on Wall Street, where she held positions of increasing responsibility at both Montgomery Securities and Kidder Peabody. Ms. Alon is the co-founder of several leading non-profit organizations to advance the technological and life sciences ecosystem in Israel, including a Covid-19 relief fund. Ms. Alon received a B.A. in Economics at the Hebrew University, Jerusalem, a M.Sc. at Columbia School of Physicians & Surgeons and an M.B.A. with a focus in Finance at Boston University.